Latest in News & Research

Microdosed Incisional Clindamycin Cuts SSI After Skin Cancer Surgery

Significantly fewer lesions receiving microdosed clindamycin, flucloxacillin required postoperative systemic antibiotics

By Elana Gotkine (HealthDay News) | | May 24, 2023

JYNNEOS Vaccine Seems Effective for Preventing Mpox

Two-dose series offers better protection, with vaccine effectiveness of 66.0 percent compared with 35.8 percent for one-dose

By Elana Gotkine (HealthDay News) | | May 19, 2023

Is Oxymetazoline Effective for Persistent Facial Erythema of Rosacea?

Clinician Erythema Assessment success rate significantly higher after oxymetazoline treatment versus vehicle

By Dermsquared Editorial Team | | May 19, 2023

Hyaluronic Acid-Based Filler Produces Midface Volume Restoration

Benefit persists for 540 days in some individuals, even without retouch

By Dermsquared Editorial Team | | May 19, 2023

Domestic Abuse Tied to Higher Risk for New Atopic Disease

Higher risk seen for asthma, atopic eczema, and allergic rhinoconjunctivitis

By Lori Solomon (HealthDay News) | | May 19, 2023

Brepocitinib Beneficial for Moderate-to-Severe Psoriatic Arthritis

Significantly greater ACR20 response rates seen at week 16 for 30 and 60 mg QD versus placebo; response maintained or improved at 52 weeks

By Elana Gotkine (HealthDay News) | | May 18, 2023

CDC Warns That Mpox Could Make a Summer Return

An outbreak in Chicago of the virus formerly called monkeypox has public health officials on edge

By HealthDay News | | May 16, 2023

People With Alopecia Have Higher Risk for Inflammatory Arthritis

Increased risk seen for psoriatic and rheumatoid arthritis, and ankylosing spondylitis

By Lori Solomon (HealthDay News) | | May 15, 2023

Skin Lesions Often First Sign of Mpox Infection in 2022 Outbreak

39 percent of patients had fewer than five lesions; papules, vesicles, pustules predominated in first five days of infection

By Dermsquared Editorial Team | | May 10, 2023

Dupilumab Beneficial for Adults With Prurigo Nodularis

All primary and key secondary end points met in two phase 3 trials of adults with PN with ≥20 nodules

By Elana Gotkine (HealthDay News) | | May 10, 2023

Mindfulness, Self-Compassion Training Improves QOL in Eczema

Intervention group showed greater improvement in Dermatology Life Quality Index score at 13 weeks and in secondary end points

By Elana Gotkine (HealthDay News) | | May 10, 2023

Electromagnetic Field Technology Plus Radiofrequency Cuts Visceral Adipose Tissue

High-intensity focused electromagnetic field technology with radiofrequency reduces VAT at three months; reduction maintained at six months

By Dermsquared Editorial Team | | May 10, 2023

Adalimumab Plus Surgery Better for Hidradenitis Suppurativa

Greater reduction seen in International HS Severity Score System and in Dermatology Life Quality Index in combination group

By Dermsquared Editorial Team | | May 05, 2023

Convolution Neural Network Aids Diagnosis for Melanocytic Lesions by Dermatologists

The most diagnostic improvement was seen for dermatologists with less dermoscopy experience cooperating with the CNN

By Dermsquared Editorial Team | | May 05, 2023

CDC Reports No New Mpox Cases in Over a Week for First Time Since Outbreak Began

Since the outbreak began last May, more than 30,000 people have been infected with the virus and 42 people have died

By Physician's Briefing Staff | | May 05, 2023

New Model Helps ID Melanoma Patients With Lymph Node Involvement

Patient-centered methodology-generated probabilities better identify patients eligible for sentinel lymph node biopsy than those generated by conventional logistic regression analysis

By Elana Gotkine (HealthDay News) | | May 05, 2023

Nearby Nature Does Not Protect Against Early Childhood Eczema

Exposure to coniferous, mixed forests and agriculture areas associated with elevated eczema risk

By Lori Solomon (HealthDay News) | | May 05, 2023

Child With Psoriasis Negatively Impacts Mom's Quality of Life

Positive association seen between mothers' Family Dermatology Life Quality Index scores and children's Psoriasis Area Severity Index scores

By Elana Gotkine (HealthDay News) | | April 28, 2023

Good Agreement Found for Clinical, Photograph Assessment of Psoriasis

Intraclass correlation coefficient 0.78 between clinical and photographic Psoriasis Area and Severity Index

By Elana Gotkine (HealthDay News) | | April 28, 2023

Anti-PD-1 More Effective With Normal Vitamin D Levels in Melanoma

Definition includes five domains of management of clinical symptoms, psychosocial elements, QoL, treatment, health care team support

By Elana Gotkine (HealthDay News) | | April 28, 2023

Chronic Hand Eczema Rapidly Improves With Gusacitinib

Significant reductions seen over placebo for 80 mg gusacitinib in mTLSS, PGA, HECSI as early as week 2

By Dermsquared Editorial Team | | April 28, 2023

Validity Demonstrated for Hidradenitis Suppurativa Investigator Global Assessment

Tool has good psychometric properties compared with existing measures

By Dermsquared Editorial Team | | April 28, 2023

Is Model With SLN Status Effective in Predicting Melanoma-Specific Death?

Model estimating five-year MSD risk that includes sentinel lymph node status provides greater net benefits across treatment thresholds

By Dermsquared Editorial Team | | April 05, 2023

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026